N/A
N=20
A Study to Evaluate the Effectiveness of Laser-Ablated Implant-Abutments to Promote Tissue Healing
Jaw, Edentulous, Partially
Bottom Line
View on ClinicalTrials.gov: NCT01822223 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcome: Primary: Number od Participants With Consistent Connective Tissue Integration at a Histologic Level — 10; 10 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Dental implant-abutments (Device)
- Age
- Adult, Older Adult · 19+ yrs
- Sex
- All
- Sponsor
- University of Alabama at Birmingham
- Primary completion
- Aug 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number od Participants With Consistent Connective Tissue Integration at a Histologic Level |
10; 10 | — |
| SECONDARY Grams of Force Needed to Disrupt Tissue Attachment to the Abutment |
— | — |
| SECONDARY Mean Change in Millimeters of Clinical Attachment to the Abutment |
— | — |
| SECONDARY Mean Change in Millimeters of Clinical Attachment to the Abutment |
— | — |
| SECONDARY Mean Change in Millimeters of Clinical Attachment to the Abutment |
— | — |
| SECONDARY Mean Change in Millimeters of Clinical Attachment to the Abutment |
— | — |
Summary
The purpose of this study is to determine which implant-abutment design is more likely to promote early soft-tissue healing processes and/or will enhance longitudinal peri-implant bone and soft-tissue health.
Eligibility Criteria
Inclusion Criteria
- At least 19 years old
- Healthy enough to under go treatment
- Have one or more edentulous sites that exhibit adequate natural bone and sufficient keratinized tissue
- Demonstrated willingness to undergo study treatment and to comply with study timeline -
Exclusion Criteria
- Full edentulism
- Any chronic health condition or medication that in the opinion of the investigators may adversely affect bone healing
- Any indication of an inability to make autonomous decisions
-
Data sourced from ClinicalTrials.gov (NCT01822223). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.